{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_572350487", "regularMarketChangePercent": -29.051384, "regularMarketPrice": 3.59, "exchange": "NGM", "shortName": "Larimar Therapeutics, Inc.", "longName": "Larimar Therapeutics, Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1403184600000, "priceHint": 4, "preMarketChange": 0.05000019, "preMarketChangePercent": 1.392763, "preMarketTime": 1684230923, "preMarketPrice": 3.64, "regularMarketChange": -1.47, "regularMarketTime": 1684180804, "regularMarketDayHigh": 4.31, "regularMarketDayRange": "3.4 - 4.31", "regularMarketDayLow": 3.4, "regularMarketVolume": 2158204, "regularMarketPreviousClose": 5.06, "bid": 0.0, "ask": 0.0, "bidSize": 10, "askSize": 31, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 4.03, "averageDailyVolume3Month": 236168, "averageDailyVolume10Day": 326440, "fiftyTwoWeekLowChange": 2.06, "fiftyTwoWeekLowChangePercent": 1.3464053, "fiftyTwoWeekRange": "1.53 - 6.85", "fiftyTwoWeekHighChange": -3.26, "fiftyTwoWeekHighChangePercent": -0.47591242, "fiftyTwoWeekLow": 1.53, "fiftyTwoWeekHigh": 6.85, "dividendDate": 1590710400, "earningsTimestamp": 1684148401, "earningsTimestampStart": 1691611200, "earningsTimestampEnd": 1692043200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.35, "epsForward": -1.23, "epsCurrentYear": -0.99, "priceEpsCurrentYear": -3.6262624, "sharesOutstanding": 43269200, "bookValue": 2.563, "fiftyDayAverage": 4.8336, "fiftyDayAverageChange": -1.2436001, "fiftyDayAverageChangePercent": -0.25728238, "twoHundredDayAverage": 4.005475, "twoHundredDayAverageChange": -0.41547513, "twoHundredDayAverageChangePercent": -0.103726804, "marketCap": 157178448, "forwardPE": -2.918699, "priceToBook": 1.4007022, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Larimar Therapeutics", "symbol": "LRMR"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Three Bala Plaza East", "address2": "Suite 506", "city": "Bala Cynwyd", "state": "PA", "zip": "19004", "country": "United States", "phone": "844 511 9056", "website": "https://www.larimartx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is headquartered in Bala Cynwyd, Pennsylvania.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carole S. Ben-Maimon M.D.", "age": 63, "title": "CEO, Pres & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 845634, "fmt": "845.63k", "longFmt": "845,634"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Celano CPA", "age": 63, "title": "Sec. & CFO", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 562621, "fmt": "562.62k", "longFmt": "562,621"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Berman", "title": "VP of Fin. & Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer Spokes Johansson", "title": "VP of Regulatory Affairs & Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nancy M. Ruiz", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gopi  Shankar M.B.A., Ph.D.", "age": 51, "title": "Chief Devel. Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Francis Michael Conway CPA", "title": "VP & Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}